Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 82,518

Document Document Title
WO/2018/126321A1
The present invention describes stable topical barrier compositions comprising primary polyamines and uses thereof for protecting the skin from external stressors, for improving skin's moisture and fort stimulating healing of the skin. T...  
WO/2018/127541A1
The invention relates to a hair growth agent consisting of an aqueous solution of alkali salts having a strong alkaline pH-Wert, pH-Wert, to the use of the agent for controlling hair loss and to a method for using said agent. The claimed...  
WO/2018/129006A1
According to an exemplary embodiment, a retainer for therapeutic treatment may be provided. The retainer for therapeutic treatment may include: a retainer that may retain a antimicrobial solution against tissue; a number of heating eleme...  
WO/2018/128104A1
[Problem] To provide a hair growth promoter containing a humus extract and having an excellent hair growth function. [Solution] The present invention provides a hair growth promoter, which has infrared absorption peaks at wave numbers of...  
WO/2018/127792A1
A method for creating a consolidated compound for delivering an immunomodulatory and imiquimod to a patient, comprising diluting immunomodulator extract to a desired dilution by transferring a desired quantity of the concentrated immunom...  
WO/2018/127435A1
The present invention relates to the novel combination of pongamia oil and 4-t-butylcyclohexanol, and to the uses thereof in the fields of cosmetics and dermatology for the treatment of redness of the skin. More specifically, the present...  
WO/2018/126041A1
Disclosed are methods and topical compositions for applying bacteria to skin, scalp and hair. The topical compositions include bacteria in a suitable base vehicle comprising honey for applying the bacteria to skin, scalp and hair. The ba...  
WO/2018/123918A1
Provided is a compound or a salt thereof, represented by the formula shown, which has a RORĪ³t inhibitory effect and is useful as a preventive or therapeutic agent for autoimmune diseases, allergies, and the like.  
WO/2018/121973A1
The invention relates to a composition comprising a plant extract of the specie Hedychium coronarium, for use in a method for treatment of the human body by therapy; and more particularly for use in protecting and/or activating at least ...  
WO/2018/124060A1
Provided is a compound represented by general formula (1) or a pharmaceutically-acceptable salt thereof. [In formula (1), R1 and R2 may be the same or different from each other, and each represents a hydrogen atom, a halogen atom, a hydr...  
WO/2018/123828A1
The present invention provides a fermented product obtained by fermenting honey and chamomile or a processed product thereof, by using Lactobacillus kunkeei.  
WO/2018/121674A1
Provided is a method by using infrared laser in a particular band to irradiate skin for significantly enhancing the biological effect generated by an exogenous RNA sequence after the sequence passes into skin. The biological effect of a ...  
WO/2018/125694A1
The invention relates to skin care compositions comprising an ethanol extract obtained from the leaves and/or stems of Arthrocnemum macrostachyum and/or Tetraena sp. cf. mandavillei. In addition, the invention relates to methods for trea...  
WO/2018/120401A1
A cosmetic composition, comprising osteogenic growth peptide carbon-terminal pentapeptide, and at least one of a carrier, a diluent, and an adjuvant. The cosmetic composition can promote the proliferation of fibroblasts and the synthesis...  
WO/2018/123968A1
In the present invention, mesenchymal stem cells cultured in a serum-free medium are used to provide a repair agent for repairing tissue damage in a living body and a method for producing said repair agent.  
WO/2018/124002A1
The purpose of the present invention is to provide: a composition for protein L-isoaspartate methyltransferase (PIMT) activation with which it is possible to activate PIMT; a novel indicator for evaluating skin restoration or repair acti...  
WO/2018/120562A1
A compound additive having a biological activation function. The compound additive contains water or phosphate buffer, and multiple proteins and various factors dissolved therein. The compound additive can be added into a culture medium ...  
WO/2018/119449A1
The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formul...  
WO/2018/116285A1
The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, R1, R2, R3, X1, X2, m and n are as defined herein, which are active as modulators of retinoid-related orphan re...  
WO/2018/113802A1
The invention relates to a medical preparation with a carrier based on hyaluronan and its derivatives which is characterized in that it comprises a conjugate of hyaluronic acid and/or its derivative with a medical substance, according to...  
WO/2018/113094A1
Disclosed is the use of a fullerene structure in the preparation of a drug for treating diabetes and complications thereof. The fullerene structure comprises at least one effective ingredient selected from the group consisting of an oil-...  
WO/2018/117153A1
The present invention relates to crystalline forms of the Janus kinase (JAK) inhibitor 3-((3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6- diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile (Compound A), as well as, compositions the...  
WO/2018/117869A1
The invention relates to a combination which is typically a composition such as a medicament and which is particularly suited for topical administration. The combination is useful in the prophylaxis and/or treatment of a range of disease...  
WO/2018/118874A1
Disclosed herein are compositions and methods of treating one or more symptom(s) related to a hyperpigmentation disorder.  
WO/2018/114720A1
The present invention relates to a mixture of arthrofactin or of a composition containing it and to the use thereof for the treatment of acneic skin.  
WO/2018/112666A1
The present disclosure provides biophotonic compositions comprising a lichen extract and a carrier medium wherein the lichen extract comprises at least one chromophore. The lichen extract is preferably derived from a lichen selected from...  
WO/2018/119176A1
A system includes an applicator mask having an applicator surface having a three dimensional shape corresponding to the isolated body part; and at least one membrane releasably disposed on the applicator surface and having an outer surfa...  
WO/2018/119288A1
Provided are methods and uses of anti-CXCR3 antibodies to treat CXCR3-associated disorders such as vitiligo. In certain embodiments, the anti-CXCR3 antibodies are humanized anti-human CXCR3 antibodies with enhanced effector function agai...  
WO/2018/112541A1
The present invention relates to methods of increasing vascular density and/or blood flow in tissue of a subject, and to increasing exercise capacity of a subject, the methods include administering to a subject an effective amount of an ...  
WO/2018/117166A1
The present invention addresses the problem of providing: a novel thiazole derivative or a pharmacologically acceptable salt thereof; a pharmaceutical composition which contains the thiazole derivative or a pharmacologically acceptable s...  
WO/2018/114715A1
The present invention relates to a synthetic polysulphated oligosaccharide having 1 to 4 monosaccharide units, the salts or complexes thereof, for use in activating epithelialisation, in particular in order to activate epithelialisation ...  
WO/2018/119444A1
The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formul...  
WO/2018/110693A1
The present invention addresses the problem of providing a film-forming preparation which contains efinaconazole, which does not leave a sticky surface after the preparation hardens, which has sufficient cohesiveness after hardening, and...  
WO/2018/108231A1
The present invention relates to novel pyrazoloazepin-8-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.  
WO/2018/109018A1
The invention relates to a capsule (1) comprising a cup composed of a least one lateral wall (2) and a lower wall (4); and a cover (3), for use thereof in a device for producing and distributing compositions, the capsule (1) comprising a...  
WO/2018/109155A1
The present invention relates to a TRPA1 receptor antagonist for use in preventing and/or treating the inflammatory component of atopic dermatitis.  
WO/2018/109541A1
The present invention is directed to methods and compositions for treatment and reduction of acne vulgaris and related skin disorders, and more specifically, to a composition comprising a combination of aluminum fluoride and sulfur as th...  
WO/2018/107694A1
A method for preventing and treating skin fibrosis, comprising administering an effective amount of plasminogen to a subject.  
WO/2018/108969A1
The instant invention provides compounds of formula I which are selective JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as atopic dermatitis, arthritis, and cancer.  
WO/2018/108230A1
The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.  
WO/2018/108910A1
The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents the treatment of inflammatory diseases and conditions.  
WO/2018/112204A1
Described herein are spiropiperidine compounds according to Formula I that have demonstrated activity as fatty acid synthase inhibitors. Also described herein are pharmaceutical compositions containing the described spiropiperidine compo...  
WO/2018/107698A1
A method for preventing and treating tissue and organ fibrosis, comprising administering an effective amount of plasminogen to a subject.  
WO/2018/109646A1
The present invention relates to a compound which is (R)-3-(1,4- dimethyl-1 H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-2-ethyl-2,3- dihydropyrido[2,3-f][l,4]oxazepin-4(5H)-yl)methyl)-4-methylp henyl) propanoic acid (I), or a pharmaceutica...  
WO/2018/109647A1
The present invention relates to bisaryl amide analogs, pharmaceutical compositions containing them and their use as NRF2 activators. In particular, the invention relates to bisaryl heterocycles of Formula (I).  
WO/2018/107693A1
A method for preventing and treating systemic sclerosis, comprising administering an effective amount of plasminogen to a subject.  
WO/2018/106694A1
The present disclosure provides dry shampoo compositions effective for cleaning hair and also moisturizing hair. The dry shampoo compositions can comprise a starch component, a conditioning agent, and optional further ingredients, such a...  
WO/2018/104874A1
The invention relates to the pharmaceutical and biotechnology industry for wound healing and organ re-epithelisation treatments. The advantages of the invention with respect to compositions of the prior art are that, in addition to accel...  
WO/2018/105738A1
Provided are: zinc chloride hydroxide that is useful as a pharmaceutical ingredient, has excellent zinc ion sustained-releasability when used as a pharmaceutical agent, and exhibits excellent stability as a pharmaceutical ingredient; and...  
WO/2018/104540A1
The present invention relates to an RNA encoding a therapeutic protein, in particular a collagenase, growth factor, cytokine, receptor, chaperone or signal transduction inhibitor. In particular, the present invention relates to RNA suita...  

Matches 1 - 50 out of 82,518